Journal articles on the topic 'Surveillance active'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Surveillance active.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Klotz, Laurence. "Active surveillance." Current Opinion in Urology 23, no. 3 (2013): 237–38. http://dx.doi.org/10.1097/mou.0b013e32835f97e9.
Full textKlotz, Laurence. "Active surveillance." Current Opinion in Urology 23, no. 3 (2013): 239–44. http://dx.doi.org/10.1097/mou.0b013e32835f8f6b.
Full textPomerantz, Mark. "Active Surveillance." Surgical Pathology Clinics 8, no. 4 (2015): 581–85. http://dx.doi.org/10.1016/j.path.2015.09.002.
Full textKlotz, Laurence. "Active surveillance." Current Opinion in Urology 22, no. 3 (2012): 222–30. http://dx.doi.org/10.1097/mou.0b013e328352598c.
Full textTsaur, I., D. Schilling, and A. Haferkamp. "Active Surveillance." Der Urologe 52, no. 6 (2013): 793–99. http://dx.doi.org/10.1007/s00120-013-3197-2.
Full textEllen, O’Connor, Kapoor Jada, Teh Jiasian, Lawrentschuk Nathan, and G. Murphy Declan. "Active Surveillance Doing Well Under Surveillance." European Urology Oncology 3, no. 1 (2020): 92–93. http://dx.doi.org/10.1016/j.euo.2019.11.006.
Full textPerlis, Nathan, and Laurence Klotz. "Contemporary Active Surveillance." Urologic Clinics of North America 44, no. 4 (2017): 565–74. http://dx.doi.org/10.1016/j.ucl.2017.07.005.
Full textSiemens, D. Robert. "Codifying active surveillance." Canadian Urological Association Journal 9, no. 5-6 (2015): 151. http://dx.doi.org/10.5489/cuaj.3018.
Full textCarter, H. Ballentine. "Optimizing Active Surveillance." European Urology 70, no. 6 (2016): 909–11. http://dx.doi.org/10.1016/j.eururo.2016.07.017.
Full textEggener, Scott. "How active should active surveillance be?" BJU International 115, no. 2 (2015): 176–77. http://dx.doi.org/10.1111/bju.12859.
Full textLoeb, Stacy, and Jeffrey J. Tosoian. "Biomarkers in active surveillance." Translational Andrology and Urology 7, no. 1 (2018): 155–59. http://dx.doi.org/10.21037/tau.2017.12.26.
Full textWallis, Christopher J. D., Laurence Klotz, Raj Satkunasivam, and Zachary Klaassen. "Not So “Active” Surveillance." International Journal of Radiation Oncology*Biology*Physics 110, no. 3 (2021): 716–17. http://dx.doi.org/10.1016/j.ijrobp.2021.01.030.
Full textChaloupka, M., T. Westhofen, A. Kretschmer, T. Grimm, C. Stief, and M. Apfelbeck. "Active Surveillance beim Prostatakarzinom." best practice onkologie 14, no. 10 (2019): 442–51. http://dx.doi.org/10.1007/s11654-019-00179-2.
Full textFernández Garay, J. C., R. Martínez Muñóz, J. Rull Hernández, N. Vidal Crespo, P. Á. López González, and G. A. Gómez Gómez. "Active surveillance: Prognostic factors." European Urology Supplements 17, no. 14 (2018): e2834. http://dx.doi.org/10.1016/s1569-9056(18)33716-3.
Full textSchmidt, Charlie. "Active Surveillance Gets Personal." Journal of the National Cancer Institute 108, no. 4 (2016): djw114. http://dx.doi.org/10.1093/jnci/djw114.
Full textChaloupka, M., T. Westhofen, A. Kretschmer, T. Grimm, C. Stief, and M. Apfelbeck. "Active Surveillance beim Prostatakarzinom." Der Urologe 58, no. 3 (2019): 329–40. http://dx.doi.org/10.1007/s00120-019-0894-5.
Full textErne, E., S. Kaufmann, K. Nikolaou, A. Stenzl, and J. Bedke. "Active Surveillance beim Prostatakarzinom." Der Urologe 58, no. 5 (2019): 511–17. http://dx.doi.org/10.1007/s00120-019-0921-6.
Full textLux, Sebastian. "„Active Surveillance war gestern“." Uro-News 16, no. 11 (2012): 20. http://dx.doi.org/10.1007/s00092-012-0426-8.
Full textLux, Sebastian. "Lebensqualität unter Active Surveillance." Uro-News 17, no. 4 (2013): 14. http://dx.doi.org/10.1007/s00092-013-0128-x.
Full textDittmar, Florian. "Active Surveillance beim Hodenkarzinom." Uro-News 27, no. 7-8 (2023): 18–23. http://dx.doi.org/10.1007/s00092-023-5743-6.
Full textHashine, Katsuyoshi, Hiroyuki Iio, Yoshiteru Ueno, Shohei Tsukimori, and Iku Ninomiya. "Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer." International Journal of Clinical Oncology 19, no. 3 (2013): 531–35. http://dx.doi.org/10.1007/s10147-013-0584-z.
Full textKovac, Evan, Gregory Lieser, Ahmed Elshafei, J. Stephen Jones, Eric A. Klein, and Andrew J. Stephenson. "Outcomes of Active Surveillance after Initial Surveillance Prostate Biopsy." Journal of Urology 197, no. 1 (2017): 84–89. http://dx.doi.org/10.1016/j.juro.2016.07.072.
Full textNarter, Fehmi. "Re: Biomarkers in Active Surveillance." Journal of Urological Surgery 5, no. 4 (2018): 232. http://dx.doi.org/10.4274/jus.2018.05.028.
Full textKlotz, Laurence. "The future of active surveillance." Translational Andrology and Urology 7, no. 2 (2018): 256–59. http://dx.doi.org/10.21037/tau.2018.01.12.
Full textDall’Era, Marc A., Benjamin J. Davies, and Scott Eggener. "Active surveillance for prostate cancer." Translational Andrology and Urology 7, no. 2 (2018): 195–96. http://dx.doi.org/10.21037/tau.2018.03.03.
Full textShill, Daniela K., Monique J. Roobol, Behfar Ehdaie, Andrew J. Vickers, and Sigrid V. Carlsson. "Active surveillance for prostate cancer." Translational Andrology and Urology 10, no. 6 (2021): 2809–19. http://dx.doi.org/10.21037/tau-20-1370.
Full textBrown, Jeffrey S., Kristen M. Moore, M. Miles Braun, et al. "Active Influenza Vaccine Safety Surveillance." Medical Care 47, no. 12 (2009): 1251–57. http://dx.doi.org/10.1097/mlr.0b013e3181b58b5c.
Full textİzol, Volkan, and Nebil Akdoğan. "Active Surveillance in Prostate Cancer." Üroonkoloji Bülteni 16, no. 4 (2017): 127–32. http://dx.doi.org/10.4274/uob.820.
Full textDonovan, Michael J., and Carlos Cordon-Cardo. "Genomic analysis in active surveillance." Current Opinion in Urology 24, no. 3 (2014): 303–10. http://dx.doi.org/10.1097/mou.0000000000000051.
Full textTay, Kae Jack, Melissa Mendez, Judd W. Moul, and Thomas J. Polascik. "Active surveillance for prostate cancer." Current Opinion in Urology 25, no. 3 (2015): 185–90. http://dx.doi.org/10.1097/mou.0000000000000168.
Full textDavis, Robert L., Margarette Kolczak, Edwin Lewis, et al. "Active Surveillance of Vaccine Safety." Epidemiology 16, no. 3 (2005): 336–41. http://dx.doi.org/10.1097/01.ede.0000155506.05636.a4.
Full textAbrahamsson, Per-Anders. "Active surveillance vs radical prostatectomy." BJU International 100, s2 Prostate Can (2007): 26–28. http://dx.doi.org/10.1111/j.1464-410x.2007.06949.x.
Full textSegaran, S., J. Jelski, and N. Burns-Cox. "Active surveillance: a cautionary tale." Journal of Clinical Urology 7, no. 2 (2014): 112–15. http://dx.doi.org/10.1177/2051415813496412.
Full textSinger, Eric A., Aradhana Kaushal, Baris Turkbey, Anna Couvillon, Peter A. Pinto, and Howard L. Parnes. "Active surveillance for prostate cancer." Current Opinion in Oncology 24, no. 3 (2012): 243–50. http://dx.doi.org/10.1097/cco.0b013e3283527f99.
Full textAlbertsen, Peter. "Who Should Consider Active Surveillance?" Journal of Urology 196, no. 6 (2016): 1604–5. http://dx.doi.org/10.1016/j.juro.2016.09.068.
Full textBangma, C. H. "Active surveillance and radical prostatectomy." European Journal of Cancer 47 (September 2011): S355—S356. http://dx.doi.org/10.1016/s0959-8049(11)70201-5.
Full textNyk, N., T. S. Dzik, M. S. Wysocki, J. D. Dobruch, P. Ch Chlosta, and A. B. Andrzej. "C58 ACTIVE SURVEILLANCE – JUSTIFIED PROCEDURE?" European Urology Supplements 10, no. 9 (2011): 627. http://dx.doi.org/10.1016/s1569-9056(11)61639-4.
Full textRüschoff, J., P. Middel, and P. Albers. "Active Surveillance des lokalisierten Prostatakarzinoms." Der Pathologe 29, no. 5 (2008): 339–47. http://dx.doi.org/10.1007/s00292-008-1013-3.
Full textBorchers, Moritz. "Die Hürden für Active Surveillance." Uro-News 23, no. 9 (2019): 10. http://dx.doi.org/10.1007/s00092-019-2337-4.
Full textLees, Kathryn, Meeta Durve, and Chris Parker. "Active surveillance in prostate cancer." Current Opinion in Urology 22, no. 3 (2012): 210–15. http://dx.doi.org/10.1097/mou.0b013e328351dc47.
Full textvan den Bergh, Roderick C. N., Ida J. Korfage, and Chris H. Bangma. "Psychological aspects of active surveillance." Current Opinion in Urology 22, no. 3 (2012): 237–42. http://dx.doi.org/10.1097/mou.0b013e328351dcb1.
Full textChen, Sharon, Monica Slavin, Quoc Nguyen, et al. "Active Surveillance of Candidemia, Australia." Emerging Infectious Diseases 12, no. 10 (2006): 1508–16. http://dx.doi.org/10.3201/eid1210.060389.
Full textRomero-Otero, Javier, Borja García-Gómez, José M. Duarte-Ojeda, et al. "Active surveillance for prostate cancer." International Journal of Urology 23, no. 3 (2015): 211–18. http://dx.doi.org/10.1111/iju.13016.
Full textCernea, Claudio R. "Active surveillance of thyroid microcarcinomas." Archives of Endocrinology and Metabolism 63, no. 5 (2019): 454–55. http://dx.doi.org/10.20945/2359-3997000000181.
Full textPhillips, Robert. "Active surveillance comes of age." Nature Reviews Urology 12, no. 2 (2015): 62. http://dx.doi.org/10.1038/nrurol.2014.363.
Full textThompson, Ian M., and Laurence Klotz. "Active Surveillance for Prostate Cancer." JAMA 304, no. 21 (2010): 2411. http://dx.doi.org/10.1001/jama.2010.1761.
Full textSaad, Fred. "Active Surveillance in Prostate Cancer." JAMA Oncology 1, no. 3 (2015): 340. http://dx.doi.org/10.1001/jamaoncol.2015.103.
Full textvan den Bergh, Roderick C. N., and Chris H. Bangma. "Active Surveillance: Protocol Makes Perfect." European Urology 67, no. 2 (2015): 239–40. http://dx.doi.org/10.1016/j.eururo.2014.06.048.
Full textMatulewicz, Richard S., Adam B. Weiner, and Edward M. Schaeffer. "Active Surveillance for Prostate Cancer." JAMA 318, no. 21 (2017): 2152. http://dx.doi.org/10.1001/jama.2017.17222.
Full textAlbertsen, Peter. "Should patients consider active surveillance?" Cancer 112, no. 12 (2008): 2631–34. http://dx.doi.org/10.1002/cncr.23500.
Full text